New test shows 87% reduction in invasive procedures for womb cancer diagnosis!

Researchers from University College London and the University of Innsbruck have developed a test called WID-qEC to replace invasive diagnostic procedures in detecting womb cancer. This test used DNA samples from 400 peri- and post-menopausal women with abnormal vaginal bleeding and identified 12 women amongst them who had womb cancer.

Currently, women with abnormal vaginal bleeding in the UK undergo procedures like transvaginal ultrasound to check the womb lining. If necessary, they might have a hysteroscopy, which involves inserting a narrow telescope into the womb, followed by a biopsy. This process can be uncomfortable and often requires multiple tests.

Now, the WID-qEC test looks for specific DNA methylation 'tags' that indicate the presence of cancer cells in the womb. In their study, the researchers found that this test successfully identified 91% of womb cancer cases, potentially reducing the need for invasive procedures by 87%.

The WID-qEC test is expected to be commercially available in Austria and Switzerland from early 2024, with plans for availability in other countries, including the UK, in the coming months. So, it's a promising development that could make diagnosing womb cancer quicker and less invasive. Exciting stuff, right?

Read the full article here 👉 https://www.pharmatimes.com/news/new_womb_cancer_test_could_prevent_need_for_invasive_diagnostic_procedures_1503586

What are your thoughts on this new development? Don't hesitate to share them here!

Take care and have a lovely day!

Somya from the Carenity team 🌼

New womb cancer test could prevent need for invasive diagnostic procedures

The WID-qEC test successfully identified 91% of womb cancer cases